Beyond the Naïve “No‐See”: Ethical Prescribing and the Drive for Pharmaceutical Transparency

@article{Oldani2009BeyondTN,
  title={Beyond the Na{\"i}ve “No‐See”: Ethical Prescribing and the Drive for Pharmaceutical Transparency},
  author={Michael Oldani},
  journal={PM\&R},
  year={2009},
  volume={1}
}
M o H r u D here was a time, not so long ago, when the American Medical Association (AMA) played a ead role in studying, policing, and literally approving the use of new pharmaceutical roducts that entered the US market. In fact, into the 1950s the AMA was an “efficient atchdog,” according to Philip Hilts [1] in his recent history of the US Food and Drug dministration, Protecting America’s Health. The AMA had its own test laboratory, published ists of fraudulent and useless drugs, and developed… Expand
The physician's relationship with the pharmaceutical industry: caveat emptor...buyer beware!
Patient and practitioner noncompliance: rationing, therapeutic uncertainty, and the missing conversation
  • C. Rouse
  • Medicine
  • Anthropology & medicine
  • 2010
Examining Reports and Policies on Cognitive Enhancement: Approaches, Rationale, and Recommendations
Special Issue for Anthropology & Medicine
Towards an era of bureaucratically controlled medical compliance ?
  • 2010

References

SHOWING 1-10 OF 31 REFERENCES
Protecting America's Health: The FDA, Business, and One Hundred Years of Regulation
Generation Rx: How prescription drugs are altering American lives, minds, and bodies
Thick prescriptions: toward an interpretation of pharmaceutical sales practices.
A historical perspective of pharmaceutical promotion and physician education.
Hooked: Ethics, the Medical Profession, and the Pharmaceutical Industry
...
1
2
3
4
...